Heacock Anne M, Dodd Michael S, Fisher Stephen K
University of Michigan, Molecular and Behavioral Neuroscience Institute Laboratories at MSRB II, 1150 West Medical Center Drive, C560, MSRB II, Ann Arbor, MI 48109-0669, USA.
J Pharmacol Exp Ther. 2006 May;317(2):685-93. doi: 10.1124/jpet.105.098467. Epub 2006 Jan 13.
The ability of the lysophospholipids sphingosine 1-phosphate (S1P) and lysophosphatidic acid (LPA) to promote the release of the organic osmolyte taurine in response to hypoosmotic stress has been examined. Incubation of SH-SY5Y neuroblastoma cells under hypoosmotic conditions (230 mOsM) resulted in a time-dependent release of taurine that was markedly enhanced (3-7-fold) by the addition of micromolar concentrations of either S1P or LPA. At optimal concentrations, the effects of S1P and LPA on taurine efflux were additive and mediated via distinct receptors. Inclusion of 1,9-dideoxyfoskolin, 5-nitro-2-(3-phenylpropylamino benzoic acid, or 4-[(2-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]-butanoic acid blocked the ability of both lysophospholipids to enhance taurine release, indicating the mediation of a volume-sensitive organic osmolyte and anion channel. Both S1P and LPA elicited robust increases in intracellular calcium concentration that were attenuated by the removal of extracellular calcium, abolished by the depletion of intracellular calcium with thapsigargin, and were independent of phosphoinositide turnover. Taurine efflux mediated by S1P and LPA was unaffected by the removal of extracellular calcium but was attenuated by depletion of intracellular calcium (34-38%) and by inhibition of protein kinase C (PKC) with chelerythrine (38-72%). When intracellular calcium was depleted and PKC was inhibited, S1P- or LPA-stimulated taurine efflux was inhibited by 80%. Pretreatment of the cells with pertussis toxin, toxin B, or cytochalasin D had no effect on lysophospholipid-stimulated taurine efflux. The results indicate that both S1P and LPA receptors facilitate osmolyte release via a phospholipase C-independent mechanism that requires the availability of intracellular calcium and PKC activity.
已对溶血磷脂鞘氨醇-1-磷酸(S1P)和溶血磷脂酸(LPA)在低渗应激反应中促进有机渗透溶质牛磺酸释放的能力进行了研究。在低渗条件(230 mOsM)下培养SH-SY5Y神经母细胞瘤细胞,会导致牛磺酸呈时间依赖性释放,添加微摩尔浓度的S1P或LPA可使其显著增强(3至7倍)。在最佳浓度下,S1P和LPA对牛磺酸外排的作用是相加的,且通过不同的受体介导。加入1,9-二脱氧佛司可林、5-硝基-2-(3-苯丙基氨基)苯甲酸或4-[(2-丁基-6,7-二氯-2-环戊基-2,3-二氢-1-氧代-1H-茚-5-基)氧基]-丁酸可阻断两种溶血磷脂增强牛磺酸释放的能力,表明其通过对体积敏感的有机渗透溶质和阴离子通道介导。S1P和LPA均引起细胞内钙浓度的强烈升高,去除细胞外钙可使其减弱,用毒胡萝卜素耗尽细胞内钙可使其消除,且其与磷酸肌醇代谢无关。由S1P和LPA介导的牛磺酸外排不受去除细胞外钙的影响,但会因细胞内钙耗尽(34%至38%)以及用白屈菜红碱抑制蛋白激酶C(PKC)(38%至72%)而减弱。当细胞内钙耗尽且PKC被抑制时,S1P或LPA刺激的牛磺酸外排被抑制80%。用百日咳毒素、毒素B或细胞松弛素D预处理细胞对溶血磷脂刺激的牛磺酸外排没有影响。结果表明,S1P和LPA受体均通过一种不依赖磷脂酶C的机制促进渗透溶质释放,该机制需要细胞内钙的可用性和PKC活性。